299 related articles for article (PubMed ID: 9815768)
1. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
Lindner DJ; Borden EC
J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106
[TBL] [Abstract][Full Text] [Related]
3. Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin.
Yokota S; Hara H; Luo Y; Seon BK
Cancer Res; 1990 Jan; 50(1):32-7. PubMed ID: 2293557
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells.
Marth C; Daxenbichler G; Dapunt O
J Natl Cancer Inst; 1986 Dec; 77(6):1197-202. PubMed ID: 3099046
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M
J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088
[TBL] [Abstract][Full Text] [Related]
7. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes.
Agarwal C; Hembree JR; Rorke EA; Eckert RL
Cancer Res; 1994 Apr; 54(8):2108-12. PubMed ID: 8174114
[TBL] [Abstract][Full Text] [Related]
8. Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin.
Bauer JA; Morrison BH; Grane RW; Jacobs BS; Dabney S; Gamero AM; Carnevale KA; Smith DJ; Drazba J; Seetharam B; Lindner DJ
J Natl Cancer Inst; 2002 Jul; 94(13):1010-9. PubMed ID: 12096086
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
Sidky YA; Borden EC
Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862
[TBL] [Abstract][Full Text] [Related]
10. The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1994; 14(5A):1779-84. PubMed ID: 7531412
[TBL] [Abstract][Full Text] [Related]
11. Effects of all-trans retinoic acid and interferon-gamma on expression of RAR beta gene in Tca8113 cells.
Chen WT; He RG; Liu XK; Zhou XJ
Chin J Dent Res; 1999 Dec; 2(3-4):25-30. PubMed ID: 10863413
[TBL] [Abstract][Full Text] [Related]
12. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells.
Abemayor E
Laryngoscope; 1992 Oct; 102(10):1133-49. PubMed ID: 1328787
[TBL] [Abstract][Full Text] [Related]
13. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.
Chawla-Sarkar M; Leaman DW; Borden EC
Clin Cancer Res; 2001 Jun; 7(6):1821-31. PubMed ID: 11410525
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction.
Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK
Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma.
Lingen MW; Polverini PJ; Bouck NP
Cancer Res; 1998 Dec; 58(23):5551-8. PubMed ID: 9850093
[TBL] [Abstract][Full Text] [Related]
17. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB
Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
[TBL] [Abstract][Full Text] [Related]
19. Interaction of retinoic acid and interferon-alpha in breast cancer cell lines.
Widschwendter M; Daxenbichler G; Bachmair F; Müller E; Zeimet AG; Windbichler G; Uhl-Steidl M; Lang T; Marth C
Anticancer Res; 1996; 16(1):369-74. PubMed ID: 8615638
[TBL] [Abstract][Full Text] [Related]
20. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis.
Lindner DJ; Borden EC
Int J Cancer; 1997 May; 71(3):456-61. PubMed ID: 9139884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
